Immune Checkpoint Inhibitors: efficacy, safety, and biomarkers - a systematic review - Quiz - MDSpire

Immune Checkpoint Inhibitors: efficacy, safety, and biomarkers - a systematic review

  • By

  • Hebatalla Ismail

  • Anees Hassan

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Immune Checkpoint Inhibitors: efficacy, safety, and biomarkers - a systematic review

  • by Hebatalla Ismail, Anees Hassan

  • May 20, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review